An inherited metabolic disorder in a strain of New Zealand White rabbits, characterized by marked hypercholesterolemia (394 ± 1 0 0 mg/dl), with moderately elevated or normal triglyceride levels is described. Low density lipoprotein (LDL), intermediate density lipoprotein (IDL) and very low density lipoprotein (VLDL) cholesterol levels were increased. VLDL and IDL, and to a lesser extent LDL, had increased free cholesterol and esterified cholesterol content, and triglyceride content was reduced. Kinetic studies with 131 I and 125 l-labelled rabbit lipoproteins showed a marked increase in production rates of VLDL apo B and LDL apo B. LDL cholesterol levels were directly related to LDL apo B production rate (r = 0.938, p < 0.001). Both in hypercholesterolemic and normal rabbits injected with labelled VLDL, the specific activity-time curves of VLDL apo B and LDL apo B did not intersect, indicating that LDL apo B was in part derived from sources other than VLDL. No defect was demonstrated in receptormediated catabolism of LDL by cultured skin fibroblasts from hyperlipidemic animals. The fractional catabolic rate of LDL apo B was subnormal, but increased when the expanded LDL apo B pool size was reduced by exchange transfusion; the low fractional catabolism may therefore be attributable, at least in part, to saturation of LDL receptors consequent upon the increased pool size of LDL. The hyperlipidemia in this strain of rabbits may be unique in that the underlying mechanism appears to be overproduction of VLDL and LDL. (Arteriosclerosis 7:105-112, March/April 1987) 
Pronounced hypercholesterolemia in a chow-fed New Zealand White rabbit was observed by one of us (ALV). The rabbit was mated with a normal female; four of the first litter of seven were hypercholesterolemic. The disorder has been transmitted vertically through matings of further affected and normal rabbits and matings of affected with affected animals. Atherosclerosis-like lesions were present. This report describes metabolic and genetic observations, and the companion paper 10 describes the arterial pathology. The abnormality appears distinct from that in the WHHL rabbit.
Methods

Animals
Among New Zealand White rabbits purchased from Buxted Rabbit Company, Buxted, Surrey, a male aged 4 months was found to have an elevated plasma cholesterol level of 351 mg/di. it was mated with two normolipidemic, nonlittermate females; several of the progeny were hypercholesterolemic ( Figure 1 ). On back-crossing an affected female with the original male, eight of the nine offspring proved to be hyperlipidemic. The metabolic and pathologic studies reported in this and the companion paper 10 were carried out on the hyperlipidemic progeny of matings between affected and nonlittermate control rabbits.
The animals were reared in individual cages after weaning. Affected and control animals received SG1 commercial rabbit feed (Grain Harvesters Limited, Canterbury) which included 10% (wt/wt) of white fish meal and con- tained 0.053% (wt/wt) of cholesterol. Hyperlipidemic and control animals received the same diet. To examine the possibility that the hyperlipidemia reflected abnormal responsiveness to a low intake of dietary cholesterol, three affected rabbits were fed, in sequence, the regular SG1 diet and diet G 680 (Grain Harvesters). The latter diet does not contain fish meal, and no cholesterol peak was detected on gas chromatography of an extract of this feed. The fat contents of the diets were 4.2% and 2.3% (wt/wt) respectively. Each diet was administered for 6 weeks, and the plasma cholesterol was measured at 2-week intervals. On SG1 the level was 251 ± 50 mg/dl, and on G 680 it was 252 ± 52 mg/dl (means ± SEM). The procedures were in conformity with institutional and statutory guidelines.
Laboratory Procedures
After an overnight fast, blood was collected into tubes containing disodium EDTA (final concentration 1 mg/ml). Plasma was prepared by low speed centrifugation. Plasma total cholesterol (Kit no. 237 574, Boehringer Mannheim, West Germany) and triglyceride (Kit no. 644 200, Boehringer Mannheim, West Germany) were measured by en-zymatJc methods. Agarose electrophoresis of plasma lipoproteins was performed by the method of Noble. 11 Gels were stained with Fat Red 7B.
Precipitation with polyanionic compounds after electrophoresis on agarose gel was performed according to the method of Seidel et al. 12 Plasma lipoproteins were fractionated by sequential preparative ultracentrifugation 13 at densities of 1.006 (VLDL), 1.019 (IDL), 1.063 (LDL), and 1.21 g/ml (HDL) at 105,000 g using a Kontron TFT 45.6 rotor (MSE, United Kingdom) according to our previously described procedure. 14 The VLDL, IDL, LDL, and HDL were overiayered with density solutions corresponding to their upper density limits and were recentrifuged for 18 to 24 hours to minimize plasma protein contamination.
For composition analysis, chylomicrons from plasma from nonfasting rabbits were isolated at 30,000 g using a Kontron TST 41.4 swinging bucket rotor. 15 The distribution of plasma total cholesterol and triglyceride within the lipoprotein classes was estimated by enzymatic assay of the isolated fractions. For the determination of lipoprotein composition, the fractions were dialyzed exhaustively against 0.01% (wt/vol) disodium EDTA, and 0.001% sodium azide (pH 7.4), prior to determination of total cholesterol and triglyceride; free cholesterol was measured by enzymatic assay (Kit 310 328, Boehringer Mannheim, West Germany). Phospholipid was determined enzymatically (Kit 991 54008; Wako Chemicals, West Germany). 18 Protein was determined by the method of Lowry et al. 17 using bovine serum albumin as the standard. The turbidity of the triglyceride-rich lipoproteins was removed with chloroform.
Aliquots of isolated lipoprotein fractions dialyzed as described were lyophilized and delipidated with chloroform/ methanol (2:1, vol/vol) for apolipoprotein analysis. SDS-PAGE 1819 was carried out in gel of 3.5% to 10% total monomer concentration on linear gradient slab gels using a gradient former (Model 385; Bio Rad, England). Electrophoresis on 12.5% total monomer slab gel with 4% stacking gel was also performed. Prior to electrophoresis, samples were solubilized in 0.06 M Tris-HCI buffer (pH 6.8) containing 10% (vol/vol) glycerol, 2% (wt/vol) SDS, and 1% (vol/vol) 6 mercaptoethanol, immersed in boiling water for 5 minutes and left at room temperature for 1 hour. Molecular weight markers of 12,300 to 78,000 and 56,000 to 280,000 daltons range (BDH Chemicals, England) were treated identically to the samples before application on the gels. Analytical isoelectric focussing was performed in the presence of pH 4-6.5 ampholines (Pharmacia Fine Chemicals, Sweden) according to a modification 20 of the method of Pagnan et al. 21 Apoproteins were stained with PAGE Blue 83 (British Drug Houses, England).
To detect plant sterols in plasma, 1 ml samples were heated with 2 M ethanolic potassium hydroxide containing 5 a-cholestane as an internal standard at 65° for 1 hour, diluted with 20% aqueous sodium chloride, and extracted with hexane. The extract was taken to dryness, redissolved in acetone and gas chromatographed on 3% OV-17 on a Gas Chrom Q column.
In dose preparation for kinetic studies, normal rabbit VLDL was labelled with 131 1 and LDL with 1 2 S I, using the ICI method 22 at pH 10; 23 in VLDL 60% of radioactivity was associated with apo B and in LDL 85% was associated with this peptide. Labelled lipoproteins were processed as previously described. 24 For metabolic studies labelled VLDL and LDL were injected i.v. into five hypercholesterolemic and four age-and weight-matched normolipidemic recipients via a marginal ear vein by use of a 25-gauge cannula which was then flushed with isotonic saline. Blood samples of about 2 ml were drawn from a contralateral ear vein on eight occasions during the ensuing 24 hours. VLDL and LDL were isolated as described. Apo B was isolated from these fractions for specific activity measurements as previously described. 24 Apo B was isolated by tetramethylurea precipitation 25 and after solubilization in 0.5 molar NaOH, was quantified by the Lowry method using bovine albumin as the primary standard. Radioactivity was measured in an LKB twin channel counter. VLDL-B radioactivity-time curves were bi-exponential, a second exponential commencing after approximately 70% of activity had disappeared. LDL-B radioactivity showed a bi-exponential disappearance curve. Fractional catabolic rates (FCRs) of VLDL-B and LDL-B were calculated from the bi-exponential curves by the procedure of Matthews. 26 Prior to the metabolic studies, the animals were maintained on diet SG1 for 3 months. Plasma cholesterol levels were stable for at least 1 month before this investigation.
In calculating apo B pool sizes, plasma volume was estimated as 3.5% of body weight. 27 Production rates (PRs) of VLDL-B and LDL-B were calculated as the products of FCR and pool size and were normalized for body weight.
Exchange transfusions were performed under general anesthesia using i.v. Hypnorm 10% in isotonic saline. A donor blood pool was obtained from normal New Zealand White rabbits, using sodium citrate 3.2% as anticoagulant; in this pool, serum cholesterol concentration was 38 mg/dl. On the day prior to exchange, LDL-apo B pool size and FCR were measured as described, using 131 I as the radiolabel. In the exchange procedure, 400 ml of blood was withdrawn via the right femoral artery over a 3-hour period, while normal blood was transfused via the right femoral vein at a similar rate. Arterial blood pressure, ECG, and plasma cholesterol were monitored. At the end of the procedure, the anesthesia was withdrawn. After 1 hour, a further tracer dose of LDL, from the same donor but radiolabelled with 12S I, was injected and the FCR and pool size of LDL apo B were again measured. In one rabbit, plasma LDL apo B pool sizes at the beginning and end of the second kinetic study were 32 mg and 37 mg, and plasma cholesterol levels were 189 mg/dl and 197 mg/dl, respectively. In the second rabbit, the pool size was initially 44 mg and at the end of the kinetic study it was 48 mg; corresponding serum cholesterol levels were 233 mg/dl and 249 mg/dl. Hence it was possible to calculate the FCR by conventional steady state analysis.
To address the possibility that LDL from affected animals showed different metabolic behavior from normal LDL, a crossover kinetic study was performed. LDL isolated from a normal rabbit was labelled with 1 3 1 I, and LDL from an affected animal was labelled with 1 2 5 I. These were simultaneously injected into two normal and two hyperiipidemic recipients, and serial blood samples were processed as described.
Cell Studies
LDL receptor activity was measured in skin fibroblasts cultured to near confluence in Dulbecco's modification of Eagle's medium containing 10% fetal calf serum. 28 Degradation of homologous 125 I-LDL was used as a measure of receptor-mediated endocytosis. 29 After derepression of fibroblasts for 24 hours in lipoprotein deficient serum, cells were incubated for 4 hours at 37°C in the presence of the labelled lipoprotein, at concentrations of LDL protein ranging from 1.5 fjjQ to 40 /^g per ml (specific activity 500 cpm/ng protein). Parallel incubations were carried out in the presence of a 20-fold excess of additional unlabelled LDL. In the study of the time course of derepression, incubations were performed for up to 24 hours in the presence of labelled LDL, 10 /xg protein/ml. After incubation, an aliquot of the medium was used for determination of noniodide, trichloroacetic acid-soluble radioactivity. 30 Cell pellets were solubilized in 0.5 M NaOH and protein content measured by the method of Lowry et al. 17 Blank values were obtained by performing identical incubations of 1 2 5 I-LDL in cell-free medium. All receptor assays were performed in quintuplicate. The results were expressed as nanograms of 125 I-LDL degraded/4 hours/mg cell protein.
Results
The plasma cholesterol levels were grossly elevated in the affected animals. In rabbits older than 4 months, cholesterol concentration was 394 ± 100 mg/dl (mean ± SD, n = 14). Triglyceride levels showed a less pronounced elevation (151 ± 59 mg/dl). Cholesterol levels increased with age in the first 3 months of life, after which there was no age-related trend. The mean cholesterol in normal males over 4 months was 77 mg/dl (standard deviation 25 mg/dl, n = 53) giving a 99th percentile of 135 mg/dl; in normal females the mean was 89 mg/dl, (standard deviation 21 mg/dl, n = 19) and trie 99th percentile was 138 mg/dl. For triglyceride levels in the fasted state, which showed no significant sex difference, the mean and standard deviation in normal animals was 84 ± 31 mg/dl, n = 12, giving a 99th percentile of 156 mg/dl.
The hypercholesterolemia reflected an almost 10-fold increase in LDL cholesterol (Table 1) , with an elevation of IDL cholesterol and of VLDL cholesterol; the milder hypertriglyceridemia was due to increases in VLDL, IDL, and LDL triglyceride (Table 1) . HDL lipid levels were not abnormal. On agarose gel electrophoresis, no differences in mobility were observed between lipoproteins from hyperiipidemic and control animals. LDL had normal beta mobility Values are means ± SEM, mg/dl. Unpaired t test (affected vs controls): *p < 0.001; tp < 0.05. and VLDL showed the typical fast pre-beta mobility of this lipoprotein in the rabbit. 31 The composition of the major lipoprotein classes is shown in Table 2 . In the LDL density class of affected rabbits, esterified and free cholesterol content were Increased, while the triglyceride content was reduced. IDL and VLDL were similarly cholesterol-enriched, with lower triglyceride content, than in control animals. HDL, too, had a somewhat higher free cholesterol and lower triglyceride content in the affected animals than in the controls. The ratio of free cholesterol to esterified cholesterol in VLDL and LDL were similar in affected and in control rabbits, but that in HDL was higher. The neutral steroid fraction of whole serum from four affected rabbits did not contain B-sltosterol or campesterol. Gradient SDS gel electrophoresis showed the expected distribution of apolipoproteins. The major band In LDL from affected and control animals was apo B-100, and a minor band with the mobility of apo E was consistently present. In VLDL and IDL, too, apo B-100 was the major band and apo E was also relatively abundant, as seen on the 3.5% to 10% gels; in the fed state, the chylomlcron fraction contained apo B-48, as well as apo B-100 and apo A-l, in both affected and normal animals. In HDL, apo A-l was the major band. Apollpoprotein patterns did not differ between the affected and control animals.
On isoelectric focussing, three apo E isoforms were identified in VLDL; the pi was slightly more acidic (5.8 to 5.6) than the corresponding human apoproteins (6.2 to 5.8). Two peptides similar to human apo C peptides were focussed In positions of pi 4.8 to 4.7. HDL showed four apo A-l isoforms; the major band had a pi similar to human A-L 2 . The isoelectric focussing patterns were identical in control and affected rabbits.
The disorder was vertically transmitted. Most offspring of the original matings of the affected male with unaffected females were hypercholesterolemic or normal, one female having combined hyperlipidemia, and the cholesterol distribution of the offspring of affected vs normal matings suggested bimodality; hypercholesterolemia with normal triglyceride levels was the commonest manifestation of the disorder (Figure 1 and Table 3 ). The litters of hypercholesterolemic vs hypercholesterolemic matings showed a range of lipid disorders with elevated levels of cholesterol, triglyceride or both lipids (Figure 1 ). In one mating of a third generation hypertriglyceridemic male with an unrelated normal female, seven of the nine offspring had combined hyperlipidemia and one was hypertriglyceridemic.
The kinetics of VLDL and LDL metabolism were studied in five affected rabbits and four controls, following i.v. injection of radioiodinated rabbit lipoproteins; 131 l-labelled VLDL and 12s l-labelled LDL were used. The VLDL apo B pool size was expanded several fold, due entirely to a sixfold increase in production rate (Table 4 ). After Injection of 131 I-VLDL, radioactivity appeared in LDL within 15 minutes, but the specific activity curve of LDL did not intersect with that of VLDL ( Figure 2 ) in any of the affected or normal animals. The mean LDL apo B production rate exceeded that of VLDL apo B in the control animals but not in the hypertipidemic ones. The expansion of the LDL apo B pool size was associated with an Increased production rate (1.11 ± 0.40 mg/kg/hr compared with 0.32 ± 0.13 mg/kg/hr, p < 0.01) and with decreased fractional catabo- lism (0.027 ± 0.007 pools/hr, compared with 0.068 ± 0.009 pools/hr, p < 0.01). From Figure 3 it is evident that there is a direct relationship between LDL cholesterol concentration and the production rate of LDL apo B in the two groups and in the combined data (r = 0.938, p < 0.001).
To determine whether the low FCR of LDL apo B was independent of the considerably expanded pool size of LDL, the metabolism of this lipoprotein was studied before and shortly after exchange transfusion in two affected 4month-okj male rabbits. In one animal, LDL cholesterol was decreased from 299 mg/dl to 66 mg/dl and the LDLapo B pool was reduced from 140 mg to 40 mg; the FCR of LDL apo B increased from 0.013 to 0.039 pools per hour. In the other, LDL cholesterol decreased from 259 mg/dl to 87 mg/dl, and the LDL apo B pool from 115 mg to 55 mg. The FCR of LDL apo B increased from 0.020 to 0.035 pools per hour.
The form of the specific activity-time curves was accurately bi-exponential in the posttransfusion studies, as in the baseline studies. During the 24-hour periods of sampling after exchange transfusion, LDL apo B pool size showed little change.
In the crossover experiment, the FCRs of LDL from a normal donor injected into two normal recipients were 0.049 and 0.060 pools/hr, and those of LDL from a hyperiipidemic donor injected into the same recipients were 0.057 and 0.058 pools/hr. When LDL was injected into two hyperlipidemic recipients, that from the normal donor was metabolized with FCRs of 0.027 and 0.026 pools/hr, while that from the affected donor disappeared with FCRs of 0.029 and 0.026 pools/hr. LDL degradation by cultured skin fibroblasts from three hyperiipidemic and three control rabbits is illustrated in Figure 4 . High-affinity, saturable binding-degradation of LDL occurred in all samples, with no indication that receptor-mediated degradation by fibroblasts from the hyperiipidemic animals was impaired. The extent of up-regulation of LDL binding during a 24-hour incubation of fibroblasts in lipoprotein-deficient medium was similar in cells from affected and from control animals ( Figure 5 ).
Discussion
The strain of rabbits described in this study appears to represent a new model of inherited, endogenous hyperiipidemia. There is predominant hypercholesterolemia due to increased levels of LDL and, to a lesser extent, to cholesteryl ester enrichment of IDL and VLDL. There was a less consistent and less pronounced hypertriglyceridemia.
Arterial intimal lesions, including lipid infiltration, were present in animals aged 4 to 18 months (see companion paper 10 ).
Unlike the Watanabe heritable hyperiipidemic (WHHL) rabbit, the St. Thomas' Hospital strain does not appear to have impaired LDL receptor function as the underlying biochemical defect. Kinetically, the elevation of VLDL levels and pool size are attributable entirely to overproduction of this density class. The increase in LDL levels and LDL apo 8 pool size, too, are chiefly attributable to overproduction (Figure 3) , the production rate of LDL apo B being linearly related to LDL cholesterol concentration over a wide range of the latter variable. Furthermore, receptormediated degradation of LDL by cultured skin fibroblasts from hyperiipidemic animals was normal. LDL apo B FCR was significantly lower in the affected animals than in controls. While this could, in theory, reflect a defect In LDL catabolism, an alternative explanation is that the low FCR was due to saturation of removal mechanisms, as a result of the expanded LDL pool. To explore these possibilities, LDL apo B FCR was measured before and after the LDL apo B pool was acutely reduced three-to fourfold by exchange transfusion with normal rabbit blood. It was evident that the subnormal FCR was at least partially dependent on saturation of removal mechanisms, since experimental reduction of pool size was associated with a marked increase in FCR. The FCR remained lower than the observed range in normal rabbits, but it was technically impossible to reduce the LDL pool to completely normal values. A crossover experiment was conducted to compare the metabolism of LDL obtained from affected and normal rabbits. The FCR of LDL from the hyperiipidemic donor was similar to that of LDL from the control, implying that there was no functional abnormality of circulating LDL.
LDL apo B overproduction is not necessarily attributable to the increased turnover of VLDL apo B, for analysis of specific activity-time curves of these lipoproteins after injection of labelled VLDL indicates that LDL apo B is derived in part from sources other than VLDL.
The mode of inheritance of the disorder has not been definitively characterized, but the vertical transmission and the suggestion of bimodaiity of cholesterol distribution are compatible with a major gene effect. Insofar as the hyperiipidemia in this rabbit strain has an analogue in human medicine, it is most comparable to familial combined hyperiipidemia 32 in which there are variably increased levels of VLDL, IDL, and LDL lipids and apo B levels, due to over-production without impairment of fractional catabol j g m 33-35 j p j g disorder is overrepresented in the families of index patients with coronary heart disease. 3 2 One difference between the human disease and that in the rabbit strain is that VLDL composition is essentially normal in the former. 34 The occurrence of arterial lesions characterized by lipid accumulation in this strain of rabbits is associated with hypercholesterolemia due to an inherited metabolic defect. The arterial pathology developed in animals receiving a normal, low fat rabbit chow. There was no evidence of widespread cholesterol deposition In other tissues. The metabolic disorder, like that of the W H H L rabbit, provides evidence of the causal relationship between hyperiipidemia and the earty events in atherogenesis. Further, it illustrates this association in a disease not characterized by impairment of receptor-mediated catabolism of LDL. As such, it has potential bearing on the signficance of common hyperlipidemic states other than familial hypercholesterolemia in humans, as potentially treatable causes of atherosclerosis. 
